Section ofObstetrics and Gynaecology 473 Table 3 Age at time of operation in 100 consecutive cases of carcinoma corporis uteri The oldest patient operated on was 85 (died at 92). The youngest patient operated on was 37 and was also the heaviest patient, her weight being 20 stone. There were 3 diabetics in the series mentioned: in none of them was there any sign of growth in the pelvis. Although they must be classed as failures, with the present methods of attack at our disposal nothing more could have been done, so that half the deaths can be included in that well-known class where the operation was successful but the patient died. Between 1943 and 1963 glands were sectioned in 76 patients; 8 (10-5%) had invaded glands, a rather higher proportion than I gave ten years ago, but this may be because it is only since then that the pathologist has received the specimens unfixed, enabling him to make a more satisfactory search for the glands. 
Results

Radiotherapy
It is generally agreed that the main treatment of adenocarcinoma of the body of the uterus is surgical since, on the one hand, this tumour is relatively resistant to radiation and, on the other, the usual slow growth and late lymphatic spread limits it to the primary site for a long time and so makes for the success of surgical treatment. Radiotherapy is of value (1) when combined with surgery, (2) as sole treatment in the now rare cases where surgery is considered inadvisable on medical grounds and (3) as a means of palliation to relieve bleeding or pain in the very advanced case.
At the Marie Curie Hospital, between 1925 and 1954, 899 cases were treated for carcinoma corporis uteri. In a recent review by Dr D J Durden Smith & Dr John Lawe (unpublished) 546 of these cases were re-examined. The others have been excluded owing to the loss of the original slides (114 cases) or the absence of confirmation of the original diagnosis on the slides available (52 cases); 132 cases were recurrent or incompletely treated for various reasons, while in 55 cases the notes were not available.
Of 121 cases treated by surgery followed by radiotherapy 88 (72-7 %) survived five years, while 42 (72 4%) of 58 cases treated more than ten years ago survived more than five years and 39 (67 2 %) survived ten years. Of 337 cases treated by radiotherapy alone more than five years ago 173 (51-3 %) survived five years, while of 266 treated more than ten years ago 142 (53-4%) survived five years and 98 (37 %°) survived ten years.
These figures are similar to those obtained in other centres; it must be remembered that the cases treated by radiotherapy tend to be more advanced locally and the patients to be more debilitated generally than those treated by surgery.
Radiotherapy Combined with Surgery Radiotherapy in cases of carcinoma corporis uteri consists either of the insertion of radium or similar sources into uterus or vagina or of the irradiation of the pelvis with supervoltage X-rays or gamma rays from a radiocobalt source. It is possible with the first to give a high dose to endometrium and vaginal mucosa but the dose falls off rapidly and outside a central cylinder of about 5 cm diameter the pelvic structures receive only a small dose. With 'supervoltage' techniques one can irradiate the whole pelvis to a high dose but bowel and bladder are inevitably irradiated as well and there is a real risk of late complications if a very high dose is given.
In the case where the tumour is clinically confined to the uterus and the main treatment is surgical the aim of radiotherapy is to reduce the risk of vaginal recurrence; in spite of precautions at the time of operation this is a real riskduring the years 1955 to 1960 I saw 36 cases of recurrence following surgery without irradiation and similar cases are seen in all radiotherapy departments.
It is my practice now to advise irradiation at the time of operation to all patients except very old women with highly differentiated small growths localized to the fundus.
T'his treatment is by intracavitary radium inserted before operation and a sterilizing dose is given to the vaginal mucosa which can be heavily irradiated while a sufficient dose is given to the uterine tumour to prevent further seedlings in the vagina during the operation. I prefer to give this treatment before operation since the uterine source is of value in irradiating the vaginal vault to a sufficiently high dose; this is difficult to achieve with vaginal sources alone after hysterectomy has been performed.
An advantage in this pre-operative treatment in young patients is that since the mucosa is adequately sterilized a long vaginal cavity may be left. The operation is performed usually about two weeks after the radium therapy when the danger of immediate complicationsespecially rectal irritationis over. It must be emphasized that certain modifications in the operation technique are necessary to reduce the interference to the structures near the bladder base which have received a heavy dose of irradiation. Hurden technique used at the Marie Curie Hospital.
I use the Hurden technique in the pre-operative irradiation of a carcinoma in a small uterus but where radiotherapy alone is to be used or where the uterus is large the Heyman (1947) technique of packing the uterus with multiple sources is to be preferred (Fig 3) . I use a modification of this technique in which I pack the uterus with small Perspex containers each containing a radiocobalt source (Figs 4 & 5; Snelling & Ellis 1959) . These sources conform with modem safety standards in being 'permanently' loaded; i.e. the radioactive Section ofObstetrics and Gyneecology 475 -~~~~~~~~~F ig 4 Perspex beads containing small radiocobalt sources and the introducer used inpacking the uterus source is sealed for eighteen months or so in a Perspex sphere which is cleaned in an ultrasonic washer and sterilized in the autoclave without unnecessary handling by the departmental staff.
Two or more sources, such as 'ovoids', in the upper vagina give the best dosage distributing to the vaginal vault and I give this treatment alone in most cases where there are no obvious deposits lower in the vagina. Where there are such deposits a long vaginal applicator is useful but in capacious vaginas extra sources are still necessary in the upper part of the vault.
Where external irradiation is to be used 'supervoltage' X-rays or the gamma rays from radiocobalt units make it possible to treat the whole pelvis to a high dose. Similar techniques are used in half or two-thirds dosage with extensive or highly malignant tumours which are to be treated by surgery laterin these cases intracavitary radium does not give a sufficient dose to the deep parts of the uterine wall. Such cases need individual consideration and a combination of a reduced dose of external irradiation with a reduced dose of intracavitary radium may be used while in other cases post-operative treatment may be given to the glands alone following a hysterectomy.
When assessing the prognosis in cases of carcinoma of the fundus the extent of the disease and the malignancy of the growth must be considered. Between 1928 and 1954, at (52 2%) survived five years, while of 321 cases of 'average' malignancy of similar extent treated in the same period 202 (62 9 %) survived for the same period. Palliative treatment cannot be discussed in detail here but I have found local irradiation with radium well worth while in stopping bleeding or discharge or in shrinking vaginal or vulval deposits, while both deep X-ray therapy and yrays are useful in treating pain caused by enlarged pelvic glands. Hormone therapy and chemotherapy I have found very disappointing and although some cases show some regression with intra-arterial chemotherapy I have found this always of very short duration.
